Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Cytomegalovirus seropositivity is independently associated with cardiovascular disease in non-dialysis dependent chronic kidney disease.

Karangizi AHK, Chanouzas D, Fenton A, Moss P, Cockwell P, Ferro CJ, Harper L.

QJM. 2019 Oct 15. pii: hcz258. doi: 10.1093/qjmed/hcz258. [Epub ahead of print]

PMID:
31613364
2.

A collaborative, individual-level analysis compared longitudinal outcomes across the International Network of Chronic Kidney Disease (iNETCKD) cohorts.

Orlandi PF, Huang J, Fukagawa M, Hoy W, Jha V, Oh KH, Sola L, Cockwell P, Levin A, Feldman HI; iNET-CKD Collaborators.

Kidney Int. 2019 Aug 30. pii: S0085-2538(19)30837-3. doi: 10.1016/j.kint.2019.07.024. [Epub ahead of print]

PMID:
31570197
3.

In Reply to 'A Psychiatrist's View on Patient-Reported Outcomes in Patients Undergoing Hemodialysis'.

Anderson NE, Calvert M, Cockwell P, Dutton M, Kyte D.

Am J Kidney Dis. 2019 Sep 18. pii: S0272-6386(19)30916-3. doi: 10.1053/j.ajkd.2019.07.009. [Epub ahead of print] No abstract available.

PMID:
31543289
4.

Cross-sectional observation study to investigate the impact of risk-based stratification on care pathways for patients with chronic kidney disease: protocol paper.

Bhachu HK, Cockwell P, Subramanian A, Nirantharakumar K, Kyte D, Calvert M.

BMJ Open. 2019 Jun 9;9(6):e027315. doi: 10.1136/bmjopen-2018-027315.

5.

Biological variation of measured and estimated glomerular filtration rate in patients with chronic kidney disease.

Rowe C, Sitch AJ, Barratt J, Brettell EA, Cockwell P, Dalton RN, Deeks JJ, Eaglestone G, Pellatt-Higgins T, Kalra PA, Khunti K, Loud FC, Morris FS, Ottridge RS, Stevens PE, Sharpe CC, Sutton AJ, Taal MW, Lamb EJ; eGFR-C Study Group.

Kidney Int. 2019 Aug;96(2):429-435. doi: 10.1016/j.kint.2019.02.021. Epub 2019 Mar 7.

PMID:
31084924
6.

The Use of Patient-Reported Outcomes in Patients Treated With Maintenance Hemodialysis: A Perspective.

Anderson NE, Calvert M, Cockwell P, Dutton M, Kyte D.

Am J Kidney Dis. 2019 Sep;74(3):399-406. doi: 10.1053/j.ajkd.2019.01.035. Epub 2019 Apr 25.

PMID:
31031088
7.

Patient and Clinician Perspectives on Electronic Patient-Reported Outcome Measures in the Management of Advanced CKD: A Qualitative Study.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Walmsley-Allen N, Slade A, McMullan C, Calvert M.

Am J Kidney Dis. 2019 Aug;74(2):167-178. doi: 10.1053/j.ajkd.2019.02.011. Epub 2019 Apr 16.

PMID:
31003865
8.

High cutoff versus high-flux haemodialysis for myeloma cast nephropathy in patients receiving bortezomib-based chemotherapy (EuLITE): a phase 2 randomised controlled trial.

Hutchison CA, Cockwell P, Moroz V, Bradwell AR, Fifer L, Gillmore JD, Jesky MD, Storr M, Wessels J, Winearls CG, Weisel K, Heyne N, Cook M.

Lancet Haematol. 2019 Apr;6(4):e217-e228. doi: 10.1016/S2352-3026(19)30014-6. Epub 2019 Mar 11.

PMID:
30872075
9.

Serum-free light chains adjusted for renal function are a potential biomarker for post-transplant lymphoproliferative disorders.

Borrows R, Scheer A, Cockwell P, Braun F, Anagnostopoulos I, Riess H, Zimmermann H, Trappe RU.

Ann Hematol. 2019 Mar;98(3):625-632. doi: 10.1007/s00277-018-03591-w. Epub 2019 Jan 25.

PMID:
30680506
10.

Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0102-7.

PMID:
30568288
11.

The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

Leung N, Bridoux F, Batuman V, Chaidos A, Cockwell P, D'Agati VD, Dispenzieri A, Fervenza FC, Fermand JP, Gibbs S, Gillmore JD, Herrera GA, Jaccard A, Jevremovic D, Kastritis E, Kukreti V, Kyle RA, Lachmann HJ, Larsen CP, Ludwig H, Markowitz GS, Merlini G, Mollee P, Picken MM, Rajkumar VS, Royal V, Sanders PW, Sethi S, Venner CP, Voorhees PM, Wechalekar AD, Weiss BM, Nasr SH.

Nat Rev Nephrol. 2019 Jan;15(1):45-59. doi: 10.1038/s41581-018-0077-4. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30510265
12.

Cardiovascular, thromboembolic and renal outcomes in IgA vasculitis (Henoch-Schönlein purpura): a retrospective cohort study using routinely collected primary care data.

Tracy A, Subramanian A, Adderley NJ, Cockwell P, Ferro C, Ball S, Harper L, Nirantharakumar K.

Ann Rheum Dis. 2019 Feb;78(2):261-269. doi: 10.1136/annrheumdis-2018-214142. Epub 2018 Nov 28.

PMID:
30487151
13.

Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England.

Nguyen NTQ, Cockwell P, Maxwell AP, Griffin M, O'Brien T, O'Neill C.

PLoS One. 2018 Nov 26;13(11):e0207960. doi: 10.1371/journal.pone.0207960. eCollection 2018.

14.

Use of an electronic patient-reported outcome measure in the management of patients with advanced chronic kidney disease: the RePROM pilot trial protocol.

Kyte D, Bishop J, Brettell E, Calvert M, Cockwell P, Dutton M, Eddington H, Hadley G, Ives NJ, Jackson LJ, Stringer S, Valente M.

BMJ Open. 2018 Oct 28;8(10):e026080. doi: 10.1136/bmjopen-2018-026080.

15.
16.

Glucocorticoid activation by 11β-hydroxysteroid dehydrogenase enzymes in relation to inflammation and glycaemic control in chronic kidney disease: A cross-sectional study.

Sagmeister MS, Taylor AE, Fenton A, Wall NA, Chanouzas D, Nightingale PG, Ferro CJ, Arlt W, Cockwell P, Hardy RS, Harper L.

Clin Endocrinol (Oxf). 2019 Jan;90(1):241-249. doi: 10.1111/cen.13889. Epub 2018 Nov 15.

17.

Incidence and impact on outcomes of acute kidney injury after a stroke: a systematic review and meta-analysis.

Arnold J, Ng KP, Sims D, Gill P, Cockwell P, Ferro C.

BMC Nephrol. 2018 Oct 22;19(1):283. doi: 10.1186/s12882-018-1085-0.

18.

A novel biomarker of laminin turnover is associated with disease progression and mortality in chronic kidney disease.

Holm Nielsen S, Guldager Kring Rasmussen D, Brix S, Fenton A, Jesky M, Ferro CJ, Karsdal M, Genovese F, Cockwell P.

PLoS One. 2018 Oct 1;13(10):e0204239. doi: 10.1371/journal.pone.0204239. eCollection 2018.

19.

Successful Renal Outcome in Membranoproliferative Glomerulonephritis Following Treatment of the Underlying Subtle Clone: A Case Report.

Rana R, Cockwell P, Vydianath B, Cook M, Pratt G, Drayson MT, Pinney JH.

Mayo Clin Proc Innov Qual Outcomes. 2018 Jun 5;2(3):297-302. doi: 10.1016/j.mayocpiqo.2018.04.003. eCollection 2018 Sep.

20.

Development and usability testing of an electronic patient-reported outcome measure (ePROM) system for patients with advanced chronic kidney disease.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Walmsley-Allen N, Auti R, Calvert M.

Comput Biol Med. 2018 Oct 1;101:120-127. doi: 10.1016/j.compbiomed.2018.08.012. Epub 2018 Aug 16.

PMID:
30130638
21.

Serum free light chain levels and renal function at diagnosis in patients with multiple myeloma.

Yadav P, Cockwell P, Cook M, Pinney J, Giles H, Aung YS, Cairns D, Owen RG, Davies FE, Jackson GH, Child JA, Morgan GJ, Drayson MT.

BMC Nephrol. 2018 Jul 13;19(1):178. doi: 10.1186/s12882-018-0962-x.

22.

Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.

Haynes R, Judge PK, Staplin N, Herrington WG, Storey BC, Bethel A, Bowman L, Brunskill N, Cockwell P, Hill M, Kalra PA, McMurray JJV, Taal M, Wheeler DC, Landray MJ, Baigent C.

Circulation. 2018 Oct 9;138(15):1505-1514. doi: 10.1161/CIRCULATIONAHA.118.034818.

PMID:
30002098
23.

Association of Elevated Urinary miR-126, miR-155, and miR-29b with Diabetic Kidney Disease.

Beltrami C, Simpson K, Jesky M, Wonnacott A, Carrington C, Holmans P, Newbury L, Jenkins R, Ashdown T, Dayan C, Satchell S, Corish P, Cockwell P, Fraser D, Bowen T.

Am J Pathol. 2018 Sep;188(9):1982-1992. doi: 10.1016/j.ajpath.2018.06.006. Epub 2018 Jul 6.

PMID:
29981742
24.

Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.

Fenton A, Jesky MD, Webster R, Stringer SJ, Yadav P, Chapple I, Dasgupta I, Harding SJ, Ferro CJ, Cockwell P.

PLoS One. 2018 May 9;13(5):e0197043. doi: 10.1371/journal.pone.0197043. eCollection 2018.

25.

Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease.

Wall NA, Dominguez-Medina CC, Faustini SE, Cook CN, McClean A, Jesky MD, Perez-Toledo M, Morgan MD, Richter AG, Ferro CJ, Cockwell P, Moss PA, Henderson IR, Harper L, Cunningham AF.

PLoS One. 2018 Apr 16;13(4):e0195730. doi: 10.1371/journal.pone.0195730. eCollection 2018.

26.

Urinary endotrophin predicts disease progression in patients with chronic kidney disease.

Rasmussen DGK, Fenton A, Jesky M, Ferro C, Boor P, Tepel M, Karsdal MA, Genovese F, Cockwell P.

Sci Rep. 2017 Dec 11;7(1):17328. doi: 10.1038/s41598-017-17470-3.

27.

Fractures in Kidney Transplant Recipients: A Comparative Study Between England and New York State.

Arnold J, Mytton J, Evison F, Gill PS, Cockwell P, Sharif A, Ferro CJ.

Exp Clin Transplant. 2018 Aug;16(4):410-418. doi: 10.6002/ect.2017.0016. Epub 2017 Nov 15.

28.

INfluence of Successful Periodontal Intervention in REnal Disease (INSPIRED): study protocol for a randomised controlled pilot clinical trial.

Sharma P, Cockwell P, Dietrich T, Ferro C, Ives N, Chapple ILC.

Trials. 2017 Nov 13;18(1):535. doi: 10.1186/s13063-017-2236-5.

29.

The Association of Serum Free Light Chains With Mortality and Progression to End-Stage Renal Disease in Chronic Kidney Disease: Systematic Review and Individual Patient Data Meta-analysis.

Fraser SDS, Fenton A, Harris S, Shardlow A, Liabeuf S, Massy ZA, Burmeister A, Hutchison CA, Landray M, Emberson J, Kalra PA, Ritchie JP, Cockwell P, Taal MW.

Mayo Clin Proc. 2017 Nov;92(11):1671-1681. doi: 10.1016/j.mayocp.2017.08.021. Epub 2017 Nov 1. Review. Erratum in: Mayo Clin Proc. 2017 Dec;92 (12 ):1866. Kalra, Phil [corrected to Kalra, Phil A].

PMID:
29101935
30.

Arterial stiffness alone does not explain arteriovenous fistula outcomes.

McGrogan DG, Stringer S, Cockwell P, Jesky M, Ferro C, Maxwell AP, Inston NG.

J Vasc Access. 2018 Jan;19(1):63-68. doi: 10.5301/jva.5000791.

PMID:
29076519
31.

A patient-centred approach to measuring quality in kidney care: patient-reported outcome measures and patient-reported experience measures.

Aiyegbusi OL, Kyte D, Cockwell P, Anderson N, Calvert M.

Curr Opin Nephrol Hypertens. 2017 Nov;26(6):442-449. doi: 10.1097/MNH.0000000000000357. Review.

PMID:
28806191
32.

Using Patient-Reported Outcome Measures (PROMs) to promote quality of care and safety in the management of patients with Advanced Chronic Kidney disease (PRO-trACK project): a mixed-methods project protocol.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Dutton M, Slade A, Marklew N, Price G, Verdi R, Waters J, Sharpe K, Calvert M.

BMJ Open. 2017 Jun 30;7(6):e016687. doi: 10.1136/bmjopen-2017-016687.

33.

Increased fracture risk in plasma cell dyscrasias is associated with poorer overall survival.

McIlroy G, Mytton J, Evison F, Yadav P, Drayson MT, Cook M, Pratt G, Cockwell P, Pinney JH.

Br J Haematol. 2017 Oct;179(1):61-65. doi: 10.1111/bjh.14815. Epub 2017 Jun 27.

PMID:
28653323
34.

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Gheorghe A, Keeley T, Slade A, Calvert M.

PLoS One. 2017 Jun 21;12(6):e0179733. doi: 10.1371/journal.pone.0179733. eCollection 2017. Review.

35.

Serum endotrophin, a type VI collagen cleavage product, is associated with increased mortality in chronic kidney disease.

Fenton A, Jesky MD, Ferro CJ, Sørensen J, Karsdal MA, Cockwell P, Genovese F.

PLoS One. 2017 Apr 12;12(4):e0175200. doi: 10.1371/journal.pone.0175200. eCollection 2017.

36.

Reflections on the national patient-reported outcome measures (PROMs) programme: Where do we go from here?

Kyte D, Cockwell P, Lencioni M, Skrybant M, Hildebrand MV, Price G, Squire K, Webb S, Brookes O, Fanning H, Jones T, Calvert M.

J R Soc Med. 2016 Dec;109(12):441-445. No abstract available.

PMID:
27923896
37.

Renal transplantation in adults.

Nieto T, Inston N, Cockwell P.

BMJ. 2016 Nov 30;355:i6158. doi: 10.1136/bmj.i6158. Review. No abstract available.

PMID:
27903494
38.

Health-Related Quality of Life Impacts Mortality but Not Progression to End-Stage Renal Disease in Pre-Dialysis Chronic Kidney Disease: A Prospective Observational Study.

Jesky MD, Dutton M, Dasgupta I, Yadav P, Ng KP, Fenton A, Kyte D, Ferro CJ, Calvert M, Cockwell P, Stringer SJ.

PLoS One. 2016 Nov 10;11(11):e0165675. doi: 10.1371/journal.pone.0165675. eCollection 2016.

39.

A population-based study of the impact of dialysis on mortality in multiple myeloma.

Evison F, Sangha J, Yadav P, Aung YS, Sharif A, Pinney JA, Drayson MT, Cook M, Cockwell P.

Br J Haematol. 2018 Feb;180(4):588-591. doi: 10.1111/bjh.14394. Epub 2016 Oct 21. No abstract available.

PMID:
27766629
40.

Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: a systematic review protocol.

Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Keeley T, Gheorghe A, Calvert M.

BMJ Open. 2016 Oct 12;6(10):e012014. doi: 10.1136/bmjopen-2016-012014.

41.

Current Trends of Renal Impairment in Multiple Myeloma.

Yadav P, Cook M, Cockwell P.

Kidney Dis (Basel). 2016 Mar;1(4):241-57. doi: 10.1159/000442511. Epub 2016 Feb 3. Review.

42.

An overview of the diagnosis and management of immunoglobulin G4-related disease.

Haldar D, Cockwell P, Richter AG, Roberts KJ, Hirschfield GM.

CMAJ. 2016 Sep 20;188(13):953-961. doi: 10.1503/cmaj.151402. Epub 2016 Jun 20. Review. No abstract available.

43.

Serum tryptase concentration and progression to end-stage renal disease.

Jesky MD, Stringer SJ, Fenton A, Ng KP, Yadav P, Ndumbo M, McCann K, Plant T, Dasgupta I, Harding SJ, Drayson MT, Redegeld F, Ferro CJ, Cockwell P.

Eur J Clin Invest. 2016 May;46(5):460-74. doi: 10.1111/eci.12622. Epub 2016 Apr 15.

PMID:
26999448
44.

Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors.

Moody WE, Ferro CJ, Edwards NC, Chue CD, Lin EL, Taylor RJ, Cockwell P, Steeds RP, Townend JN; CRIB-Donor Study Investigators.

Hypertension. 2016 Feb;67(2):368-77. doi: 10.1161/HYPERTENSIONAHA.115.06608.

45.

Association between periodontitis and mortality in stages 3-5 chronic kidney disease: NHANES III and linked mortality study.

Sharma P, Dietrich T, Ferro CJ, Cockwell P, Chapple IL.

J Clin Periodontol. 2016 Feb;43(2):104-13. doi: 10.1111/jcpe.12502. Epub 2016 Feb 18.

46.

Correction: The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.

Assi LK, McIntyre N, Fraser S, Harris S, Hutchison CA, McIntyre CW, Cockwell P, Taal MW.

PLoS One. 2015 Oct 20;10(10):e0141404. doi: 10.1371/journal.pone.0141404. eCollection 2015. No abstract available.

47.

Methods Used in Economic Evaluations of Chronic Kidney Disease Testing - A Systematic Review.

Sutton AJ, Breheny K, Deeks J, Khunti K, Sharpe C, Ottridge RS, Stevens PE, Cockwell P, Kalra PA, Lamb EJ; eGFR-C study group.

PLoS One. 2015 Oct 14;10(10):e0140063. doi: 10.1371/journal.pone.0140063. eCollection 2015. Review.

48.

Caveolin-1 single-nucleotide polymorphism and arterial stiffness in non-dialysis chronic kidney disease.

Chand S, Edwards NC, Chue CD, Jesky M, Stringer S, Simmonds MJ, Duff CE, Cockwell P, Harper L, Steeds RP, Townend JN, Ferro CJ, Borrows R.

Nephrol Dial Transplant. 2016 Jul;31(7):1140-4. doi: 10.1093/ndt/gfv350. Epub 2015 Oct 3.

PMID:
26433014
49.

Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial.

Bhandari S, Ives N, Brettell EA, Valente M, Cockwell P, Topham PS, Cleland JG, Khwaja A, El Nahas M.

Nephrol Dial Transplant. 2016 Feb;31(2):255-61. doi: 10.1093/ndt/gfv346. Epub 2015 Sep 30.

50.

Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.

Yadav P, Hutchison CA, Basnayake K, Stringer S, Jesky M, Fifer L, Snell K, Pinney J, Drayson MT, Cook M, Cockwell P.

Eur J Haematol. 2016 Jun;96(6):610-7. doi: 10.1111/ejh.12644. Epub 2015 Sep 16.

PMID:
26248588

Supplemental Content

Loading ...
Support Center